Joint R&D 2020: "IMPACT: Invigorating precision Medicine by Predictive imaging of sdAb-based anti-Cancer Theranostics"

Project Details

Description

we propose to develop radiolabelled single domain antibodies (sdAbs) as theranostics to identify biomarkers with in vivo molecular imaging in the tumour and its environment.
AcronymBRGRD44
StatusActive
Effective start/end date1/07/2030/06/23

Flemish discipline codes

  • Nuclear imaging

Keywords

  • single domain antibody fragments
  • nuclear imaging
  • targeted radionuclide therapy